Loading
Optain Health is a healthcare technology company based in New York City, specializing in AI-powered retinal imaging and oculomics. Founded in 2023, it aims to enhance preventive health by providing clinicians with non-invasive, real-time diagnostic tools that can screen for over 140 eye and systemic conditions, such as diabetic retinopathy and cardiovascular disease risk. The company emerged from a collaboration between Aegis Ventures and Northwell Holdings, building on research led by Professor Mingguang He. Optain offers an integrated platform that includes the Resolve portable robotic retinal camera and the Assure AI diagnostic software. This combination allows for immediate analysis of retinal images, making it suitable for various healthcare settings, including primary care clinics and teleophthalmology. The company also provides teleophthalmology services and clinical consulting to support health systems in implementing its technology. With a focus on accessibility and cost-effectiveness, Optain Health is positioned to improve patient outcomes and streamline healthcare delivery.